Shëndeti

EMA approves world's first weekly diabetes insulin

EMA approves world's first weekly diabetes insulin

The European Medicines Agency (EMA) has approved the world's first weekly insulin for the treatment of adult patients with diabetes. Thus, the number of insulin administrations will be reduced to just once a week compared to the daily administration that is currently done. In one year, from a minimum of 365 injections, it goes to 52. This was announced by the pharmaceutical company Novo Nordisk.

As well as helping to improve patients' quality of life, the new weekly insulin also has an impact on environmental sustainability, promoting the reduction of CO2 emissions.

. Today, insulin therapy requires the patient to administer insulin at least once a day with an impact ranging from the management of the therapy itself to the social, work and psychological spheres of the person and their families.